ClinicalTrials.gov record
Not listed Not applicable Interventional

BAROSTIM® Hope for Heart Failure Study

ClinicalTrials.gov ID: NCT01720160

Public ClinicalTrials.gov record NCT01720160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 6:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Barostim HOPE4HF Study

Study identification

NCT ID
NCT01720160
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Lead sponsor
CVRx, Inc.
Industry
Enrollment
98 participants

Conditions and interventions

Conditions

Interventions

  • BAROSTIM NEO® System Device
  • Standard of care medical managment therapy for heart failure Other

Device · Other

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2012
Primary completion
Apr 30, 2015
Completion
Feb 28, 2021
Last update posted
May 13, 2019

2012 – 2021

United States locations

U.S. sites
23
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
Southwest Cardiovascular Associates Mesa Arizona 85206
Arizona Heart Rhythm Research Center Phoenix Arizona 53226
University of Southern California Los Angeles California 90033
George Washington University Washington D.C. District of Columbia 20037
ACRC - Cardiology Atlantis Florida 33462
AdventHealth Orlando Orlando Florida 32803
Tampa General Hospital Tampa Florida 33606
Piedmont Heart Institute Atlanta Georgia 30309
Advocate Medical Group Naperville Illinois 60540
Cardiovascular Institute of the South Houma Louisiana 70360
St Elizabeth's Medical Center Brighton Massachusetts 02135
Mid-Michigan Medical Center Midland Midland Michigan 48670
Cardiac & Vascular Research Center of Northern Michigan Petoskey Michigan 49770
University of Mississippi Medical Center Jackson Mississippi 39216
University Medical Center of Southern Nevada Las Vegas Nevada 89102
Hackensack University Medical Center Hackensack New Jersey 07601
The Ohio State University Columbus Ohio 43210
Oklahoma Cardiovascular Research Group Oklahoma City Oklahoma 73120
Drexel University College of Medicine Philadelphia Pennsylvania 19102
Allegheny General Hospital Pittsburgh Pennsylvania 15212
Lonestar Heart Center Amarillo Texas 79106
Wheaton Franciscan Healthcare Milwaukee Wisconsin 53215
Aspirus Heart & Vascular Institute Wausau Wisconsin 55401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01720160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2019 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01720160 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →